Alabama VIP Older Driver Study and Tebentafusp To Treat Uveal Melanoma On May 23 Show

Dr. Cynthia Owsley (University of Alabama at Birmingham - Birmingham, AL)

Dr. Bartosz Chmielowski (University of California at Los Angeles - Los Angeles, CA)

Dr. Cynthia Owsley, Nathan E. Miles Chair of Ophthalmology at the University of Alabama at Birmingham Department of Ophthalmology and Visual Sciences, discusses the Alabama VIP Older Driver Study, which used unobtrusive sensors and cameras in vehicles to link older drivers' visual impairment to at-fault traffic accidents.

Then, Dr. Bartosz Chmielowski, an assistant clinical professor of hematology and medical oncology at UCLA Jonsson Comprehensive Cancer Center, explains a drug, tebentafusp, that could be used to be treat uveal melanoma, a form of eye cancer.  

 5/23/2021 Podcast (Click Image Below)

Citicoline To Help and Glaucoma and Results From Ocular Hypertension Treatment Study On May 9 Show

Dr. Kevin Chan (NYU Langone Health - New York, NY)

Dr. Michael Kass (Washington University School of Medicine - St. Louis, MO)

Dr. Kevin Chan, an assistant professor of ophthalmology and radiology, at NYU Langone Health in New York, discusses a compound called citicoline, which contains choline, that has proven to assist rats to regain nerve connection between the brain and the eye in treating glaucoma.

Then, Dr. Michael Kass, the Bernard Becker Professor of Ophthalmology and Visual Sciences at Washington University School of Medicine in St. Louis, goes over the results of the Ocular Hypertension Treatment Study, which purpose was to determine how necessary treatment for elevated eye pressure was to prevent vision loss from glaucoma.

5/9/2021 Podcast (Click Image Below)